- Home
- LGTY vs MNMD Comparison
LGTY vs MNMD Comparison
Compare LGTY & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGTY
- MNMD
- Stock Information
- Founded
- LGTY 1970
- MNMD 2019
- Country
- LGTY United States
- MNMD United States
- Employees
- LGTY N/A
- MNMD N/A
- Industry
- LGTY
- MNMD Pharmaceuticals and Biotechnology
- Sector
- LGTY
- MNMD Health Care
- Exchange
- LGTY NYSE
- MNMD Nasdaq
- Market Cap
- LGTY 411.9M
- MNMD 485.5M
- IPO Year
- LGTY N/A
- MNMD N/A
- Fundamental
- Price
- LGTY $11.08
- MNMD $7.52
- Analyst Decision
- LGTY
- MNMD Strong Buy
- Analyst Count
- LGTY 0
- MNMD 9
- Target Price
- LGTY N/A
- MNMD $28.75
- AVG Volume (30 Days)
- LGTY 134.2K
- MNMD 1.8M
- Earning Date
- LGTY 11-21-2024
- MNMD 11-07-2024
- Dividend Yield
- LGTY 3.98%
- MNMD N/A
- EPS Growth
- LGTY N/A
- MNMD N/A
- EPS
- LGTY 0.32
- MNMD N/A
- Revenue
- LGTY $102,806,000.00
- MNMD N/A
- Revenue This Year
- LGTY N/A
- MNMD N/A
- Revenue Next Year
- LGTY N/A
- MNMD N/A
- P/E Ratio
- LGTY $34.96
- MNMD N/A
- Revenue Growth
- LGTY N/A
- MNMD N/A
- 52 Week Low
- LGTY $8.41
- MNMD $2.69
- 52 Week High
- LGTY $12.27
- MNMD $12.22
- Technical
- Relative Strength Index (RSI)
- LGTY N/A
- MNMD 54.99
- Support Level
- LGTY N/A
- MNMD $6.70
- Resistance Level
- LGTY N/A
- MNMD $9.85
- Average True Range (ATR)
- LGTY 0.00
- MNMD 0.80
- MACD
- LGTY 0.00
- MNMD -0.04
- Stochastic Oscillator
- LGTY 0.00
- MNMD 41.46
About LGTY LOGILITY SUPPLY CHAIN SOLUTIONS INC
Logility Supply Chain Solutions Inc develops enterprise management and supply chain-related software and services. Its Services include Scenario Planning Products, Demand Planning InventoryAI+, Supply, Deployment, Supply Chain Data Management, and Supply Chain Design. The group provides services to various industries such as Food and Beverage Consumer Packaged Goods, Process Manufacturing, Industrial Manufacturing, Chemicals, and others.
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.